Microalbuminuria,1331
Microcephaly,incongenitalbraindisease,1396
Microchromosomalanomalies,1410–1412
deletion22q11.2(DiGeorge/velocardiofacialsyndrome),1410–1411,1411t
monogenicsyndromes,1412–1419
Williamssyndrome,1412,1412f,1412t
Micro-computedtomography,88,90f
MicroRNAs,cardiacdevelopmentand,51
Microvasculature,endothelialfunctionin,1368,1369f
Mid-AtlanticGroupofInterventionalCardiology,1511t–1514t
Middlecerebralartery,pulse-waveDoppler,129–130,130f
Milrinone
foracutecirculatoryfailure,1184t
forhypotensionandcirculatorycollapse,inprematurity,204
Mineralocorticoidexcess,apparent,hypertensionin,1137
Minimallyinvasiveapproaches,218–219,219f
Minoxidilforhypertension,1140t–1141t
Minuteventilation,384–385
Mirrorimaging,onultrasoundimages,283
Mitochondria,incardiomyocyte,74–75,75f
Mitochondrialcardiomyopathies,1148
Mitochondrialmyopathies,cardiacinvolvementin,1097
Mitralarcade,611
Mitralcleft,612–613,613f
Mitralinsufficiency
pure,617–618
stenosisversus,616
Mitralregurgitation
inchronicrheumaticheartdisease,1026
interventionaltechniquesfor,263
inKawasakisyndrome,983
inrheumaticfever,1004,1007b
Mitralstenosis,618
inchronicrheumaticheartdisease,1026
percutaneousmanagementof,1034
incompetenceversus,616
interventionaltechniquesfor,263
Mitralvalve
accessorytissue,614,614f
indiagnosticcatheterization,250
dual-orifice,614,614f
morphogenesisof,607,609f–611f
operations,1036–1037
repair,1036,1038f–1041f
replacement,1037,1038f
three-dimensionalechocardiographyof,314t
Mitralvalvediseases,607–630,608t,seealsospecificabnormalities
cardiaccatheterizationin,623–624
chestradiographyin,618
chronicrheumaticheartdiseaseand,1027,1028f–1030f,1028b
classificationof,609–611
clinicalpresentationof,617–618
computedtomographyin,623,624f
courseof,624
differentialdiagnosisof,624
dysplastic,611–613
echocardiographyin,618,618f
cross-sectional,618–620,619f–621f
Doppler,621–622,621f–622f
three-dimensional,622–623,623f
effectonheart,616
electrocardiographyin,618
essentiallydouble-outletventriculoarterialconnectionstogetherwithanterosuperiorinterventricular
muscularcommunication,616,616f
etiologyof,616–617
withexcessofleaflettissue,616
inhypoplasticleftheartsyndrome,614,615f
incidenceof,616–617
magneticresonanceimagingin,623
medicalmanagementof,625
morphologyof,607–616,612f
pathophysiologyof,617
prognosisof,624
surgicalmanagementof,625–630
complicationsin,629,630f
mitralvalverepair,625
mitralvalvereplacement,627
riskfactorsandlong-termresultsin,629–630
Mitralvalveprolapse,616
Mitralvalverepair,625
onannulus,626,629f
onleaflets,625–626,628f–629f
onsubvalvarapparatus,625
chords,625,627f–628f
papillarymuscles,625,626f–627f
onsupraannularlevel,626,629f
Mitralvalvereplacement,627
biologic,627–629,630f
mechanical,627
Mixedα-andβ-adrenoreceptorblockers,forhypertension,1140,1140t
Mixedanomalousconnection,479
Mixeddrainage,476
M-modeechocardiography,measurementofatrioventricularringdisplacement
with,96–97
M-modeimaging,285
MobitztypeIAVblock,337–338,337f